Disperazol Pharma ApS
PrivateLast Round
Grant
Jun 5, 2023
Total Funding Raised
$10,800
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Disperazol Pharma ApS is a biotechnology company that develops non-traditional antimicrobial compounds designed to dismantle biofilms of Gram-negative pathogens to enhance the efficacy of existing antibiotics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Disperazol Pharma ApS Comparables
Compare Disperazol Pharma ApS with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioTryp Therapeutics | 85% | |
| Resistia | 82% | |
| HHV Biotech | 80% | |
Disperazol Pharma ApS Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 5, 2023 |
Disperazol Pharma ApS Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| INCATE | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2026
Monthly visitors grew 416% MoM, from 251 to 1.3K.
- Jun 5, 2023
$11K grant received from INCATE.
Disperazol Pharma ApS Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Disperazol Pharma ApS's valuation, stock price, and market status.